There is no local or national source that accurately quantifies drugs entering or circulating in terms of absolute volume. Overdose mortality data are a useful metric because it's the outcome that matters most to most people. But it is at best a proxy for the drug supply.
Specific substances identified in mortality data are limited by what is assayed for and how they are named in death records.
Death records in many, but not all, states are public information.
Causal emphasis on what substance was involved in an overdose can vary by coroner or medical examiner, a longstanding problem that has made considerable strides.
Death certificates are limited by what is measured and recorded. They often contain little/no mental health and social antecedents.
We cannot systematically distinguish intentional vs. accidental polysubstance use from mortality data.
Most models do not account for if people moved or died of other causes.
ICD-10 coding using T-codes lumps illicitly manufactured fentanyl with pharmaceutical fentanyl.
Most data dashboards include unintentional deaths and suicides.
Presence of a substance in post-mortem body fluids doesn't automatically mean that that substance was involved in the fatal event.
Stimulant-related toxicity has a lot of variation in how it is ascribed in a death.
There is a 4-18 month delay in cause of death investigations, varying by state resources. Not all states have the same resources for these investigations.
Coroner-based systems (in contrast to medical examiners) may have less specific causes of death. Some states have coroners, others do not.